Stocks  /  NASDAQ  /  Rapport Therapeutics Inc.

Rapport Therapeutics Inc.

Industry:   Health Care – Biotechnology: Pharmaceutical Preparations

Stock Symbol:   RAPPNASDAQ

 

Animal Usage:   Animal Testing

Our Opinion

Rapport Therapeutics Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated on its website that it uses animals for product testing.

“TARPγ8 inhibition has demonstrated preclinical activity in third-party pain models and pain behavior improvements in animal models of acute, inflammatory, and neuropathic pain.” Read the following article

Company Description

Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders. The company was formerly known as Precision Neuroscience NewCo, Inc. and changed its name to Rapport Therapeutics, Inc. in October 2022. Rapport Therapeutics, Inc. was incorporated in 2022 and is based in Boston, Massachusetts.

Company Website: https://www.rapportrx.com

Contact:  investors@rapportrx.com
Scroll to Top